US National Cancer Institute to test seven novel cancer drugs from Clavis Pharma
29-May-2007 -
Clavis Pharma announced that the US National Cancer Institute has accepted seven new compounds from the company for testing under its Developmental Therapeutics Program. The drug candidates, which are structurally novel analogues of several cancer drugs, have been synthesized by applying Clavis ...
cell lines
documentation